Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma

被引:87
作者
Hall, FT
Freeman, JL
Asa, SL
Jackson, DG
Beasley, NJ
机构
[1] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Hlth Network, Dept Pathol, Toronto, ON, Canada
[3] John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DU, England
关键词
D O I
10.1001/archotol.129.7.716
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To examine the relationship between lymphatic vessel density and clinical and pathological variables in patients with well-differentiated papillary thyroid carcinoma. Subjects: Clinical information was retrieved on 109 previously untreated patients with well-differentiated papillary thyroid carcinoma treated with total thyroidectomy and postoperative iodine 1 131 ablation. Median follow-up was 38 months. Design: Archived tissue specimens were sectioned and stained with hematoxylin-eosin and anti-LYVE-1 antibody, a highly specific marker for lymphatic endothelium. The size of the tumor and its multifocality were noted and lymphatic vessel density was measured by means of Chalkley point counting. Results: Numerous intratumoral lymphatics were seen in papillary thyroid carcinoma. There was a highly significant association between the presence of intratumoral lymphatics and the presence of neck node metastases (P<.001). There was also a significant association with male sex (P=.03) and the presence of multifocal disease (P=.05). The presence of intratumoral lymphatics remained significantly associated with the presence of nodal metastases at presentation (P=.003) on multivariate analysis. Intratumoral lymphatics were not a significant predictor of tumor recurrence (P=.42, log-rank test) Conclusions: The development of intratumoral lymphatics in well-differentiated papillary thyroid carcinoma appears to be associated with the spread of tumor to regional lymph nodes. The antimetastatic potential of targeting these lymphatics may be of potential therapeutic benefit in the future.
引用
收藏
页码:716 / 719
页数:4
相关论文
共 27 条
[1]   LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan [J].
Banerji, S ;
Ni, J ;
Wang, SX ;
Clasper, S ;
Su, J ;
Tammi, R ;
Jones, M ;
Jackson, DG .
JOURNAL OF CELL BIOLOGY, 1999, 144 (04) :789-801
[2]   Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer [J].
Beasley, NJP ;
Lee, J ;
Eski, S ;
Walfish, P ;
Witterick, I ;
Freeman, JL .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (07) :825-828
[3]  
Beasley NJP, 2002, CANCER RES, V62, P1315
[4]   Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries -: Podoplanin as a specific marker for lymphatic endothelium [J].
Breiteneder-Geleff, S ;
Soleiman, A ;
Kowalski, H ;
Horvat, R ;
Amann, G ;
Kriehuber, E ;
Diem, K ;
Weninger, W ;
Tschachler, E ;
Alitalo, K ;
Kerjaschki, D .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) :385-394
[5]   Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features [J].
Bunone, G ;
Vigneri, P ;
Mariani, L ;
Butó, S ;
Collini, P ;
Pilotti, S ;
Pierotti, MA ;
Bongarzone, I .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1967-1976
[6]   Tumour angiogenesis and prognosis [J].
Fox, SB .
HISTOPATHOLOGY, 1997, 30 (03) :294-301
[7]   Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling [J].
He, YL ;
Kozaki, KI ;
Karpanen, T ;
Koshikawa, K ;
Yla-Herttuala, S ;
Takahashi, T ;
Alitalo, K .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (11) :819-825
[8]  
Hughes CJ, 1996, HEAD NECK-J SCI SPEC, V18, P127, DOI 10.1002/(SICI)1097-0347(199603/04)18:2<127::AID-HED3>3.0.CO
[9]  
2-3
[10]   LYVE-1, the lymphatic system and tumor lymphangiogenesis [J].
Jackson, DG ;
Prevo, R ;
Clasper, S ;
Banerji, S .
TRENDS IN IMMUNOLOGY, 2001, 22 (06) :317-321